GST Council likely to exempt IGST on cancer drug Dinutuximab import

Import of cancer medicine Dinutuximab (Qarziba) by individuals for personal use attract a 12 percent IGST.

Published On 2023-07-07 09:00 GMT   |   Update On 2023-07-07 09:00 GMT
Advertisement

New Delhi: The GST Council at its next meeting on Tuesday is likely to exempt cancer medicine Dinutuximab imported by individuals from tax, decide on applicability of GST on food or beverages served in multiplexes and come out with a clear definition of utility vehicles for levying a 22 per cent cess, sources said.

The Council, chaired by Union finance minister and comprising state ministers, will also decide on GST exemption for satellite launch services provided by private players.
Advertisement
Besides, import of medicines and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases for personal use and also by centres of excellence are likely to be exempted from Integrated GST. Currently, such imports attract an IGST of 5 per cent or 12 per cent.

The fitment committee, comprising central and state tax officers, has recommended to the Council to clarify on these major issues at the 50th meeting of the Council on July 11.

In addition to the recommendations of the fitment committee, the Council will also consider the GoM report on online gaming, finalise contours for setting up appellate tribunal, and demand of the industry for reimbursement of full CGST and 50 per cent IGST in 11 hill states under the ‘scheme for budgetary support’.

With regard to rates, the fitment committee has recommended to the Council to define Multi Utility Vehicles (MUV) or multipurpose vehicles or crossover utility vehicles (XUVs) at par with the Sports Utility Vehicles (SUVs) for levy of a 22 per cent compensation cess over and above the 28 per cent Goods and Services Tax (GST) rate, sources said.

The committee has recommended that all utility vehicles, by whatever name called, would attract 22 per cent cess provided they meet three parameters — length greater than 4-metre, engine capacity greater than 1,500 cc and ground clearance in ‘un-laden condition’ of more than 170 mm.

The GST Council had in December last year clarified on the definition of SUVs. At that time, some states had asked for a similar clarification for MUVs.

The fitment committee has asked the GST Council to clarify that food and beverages served in cinema halls be taxed at 5 per cent and not 18 per cent as was being done in some multiplexes. Karnataka had raised the issue and demanded clarity from the Council.

The food or beverages served in a cinema hall is taxable as restaurant service, the committee said.

However, if the sale of cinema ticket and supply of eatables such as popcorn or cold drinks etc. are clubbed and sold together, the entire supply should be treated as composite supply and taxed as per the applicable rate of the principal supply, which in this case is cinema ticket.

Currently, movie tickets below Rs 100 are taxed at 12 per cent, while those above the threshold attract an 18 per cent GST.

Import of cancer medicine Dinutuximab (Qarziba) by individuals for personal use attract a 12 per cent IGST. The fitment committee said that the medicine which costs Rs 36 lakh should be exempted from GST as patients usually raise money through crowdfunding.

As regards satellite launch services, public sector enterprises like ISRO, Antrix Corporation Ltd (ACL) and New Space India Ltd (NSIL) are exempt from GST. However, private players are required to pay an 18 per cent tax.

As India is emerging as a strong player in global commercial space market, the fitment committee suggested that exemption should be extended to the private players also with a view to provide level-playing field.

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News